Comparative effect of angiotensin II type I receptor blockers and calcium channel blockers on laboratory parameters in hypertensive patients with type 2 diabetes

被引：0
|
作者：
Yayoi Nishida
Yasuo Takahashi
Tomohiro Nakayama
Satoshi Asai
机构：
[1] Nihon University School of Medicine,Division of Genomic Epidemiology and Clinical Trials, Advanced Medical Research Center
[2] Nihon University School of Medicine,Division of Clinical Trial Management, Advanced Medical Research Center
[3] Nihon University School of Medicine,Division of Pharmacology, Department of Biomedical Sciences
[4] Nihon University School of Medicine,Division of Laboratory Medicine, Department of Pathology and Microbiology
来源：
Cardiovascular Diabetology | / 11卷
关键词：
Angiotensin II receptor blocker (ARB); Calcium channel blocker (CCB); Hematological parameter; Retrospective observational study;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] COMPARATIVE EFFECTIVENESS STUDY OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN RECEPTOR BLOCKERS IN PATIENTS WITH TYPE 2 DIABETES
    Campbell, H. M.
    Khan, N.
    Raisch, D. W.
    Borrego, M.
    Sather, M.
    Murata, G. H.
    VALUE IN HEALTH, 2012, 15 (04) : A172 - A172
  • [32] Effects of L-/N-Type Calcium Channel Blockers on Angiotensin II-Renin Feedback in Hypertensive Patients
    Kawabata, Yutaka
    Soeki, Takeshi
    Ito, Hiroyuki
    Matsuura, Tomomi
    Kusunose, Kenya
    Ise, Takayuki
    Yamaguchi, Koji
    Tobiume, Takeshi
    Yagi, Shusuke
    Fukuda, Daiju
    Yamada, Hirotsugu
    Wakatsuki, Tetsuzo
    Kitani, Mitsuhiro
    Kawano, Kazuhiro
    Taketani, Yoshio
    Sata, Masataka
    INTERNATIONAL JOURNAL OF HYPERTENSION, 2020, 2020
  • [33] Renoprotection in type 2 diabetes: blockade of the renin-angiotensin system with angiotensin II receptor blockers
    Swift, PA
    MacGregor, GA
    JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM, 2001, 2 (03) : 170 - 173
  • [34] Angiotensin-receptor blockers, type 2 diabetes, and renoprotection.
    Walser, M
    NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (09): : 706 - 706
  • [35] ACE inhibitors or angiotensin receptor blockers for prevention of type 2 diabetes
    Abuissa, H
    O'Keefe, J
    Bell, D
    Jones, P
    Marso, S
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (03) : 10A - 10A
  • [36] ANGIOTENSIN RECEPTOR BLOCKERS AND RISK OF CARDIOVASCULAR DEATH IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
    Phung, O. J.
    Sakharkar, P. R.
    Law, A., V
    VALUE IN HEALTH, 2012, 15 (04) : A171 - A171
  • [37] Reduction of microalbuminuria by calcium channel blockers in patients with type 2 diabetes mellitus and hypertension
    Hwang, Y. -C.
    Oh, S.
    Yoon, K. -H.
    Cha, B.
    Lee, K. -W.
    Jang, H.
    Min, K.
    Chung, C.
    Lee, M. -K.
    DIABETOLOGIA, 2014, 57 : S488 - S488
  • [38] Angiotensin type 2 receptor contributes to vascular responses in resistance arteries of type 2 diabetic hypertensive patients treated with angiotensin type 1 receptor blockers
    Savoia, Carmine
    Touyz, Rhian M.
    Schiffrin, Ernesto L.
    HYPERTENSION, 2006, 48 (04) : E43 - E43
  • [39] Arterial hypertension and Type 2 diabetes mellitus: any benefits for angiotensin II receptor blockers?
    Fomin, V. V.
    Moiseev, S. V.
    Saginova, E. A.
    CARDIOVASCULAR THERAPY AND PREVENTION, 2007, 6 (03): : 126 - 131
  • [40] Prescription data related to the use of calcium channel blockers, ACE inhibitors and angiotensin II type 1 receptor antagonists (angiotensin receptor blockers) in combination identify savings opportunities
    Carugo S.
    Rossetti G.
    Merlino L.
    Mancia G.
    High Blood Pressure & Cardiovascular Prevention, 2009, 16 (1) : 21 - 26
12345